540729
VANTABIO
Start SIP
Invest Now
Start SIP in VANTABIO
Performance
- Low
- ₹20
- High
- ₹20
- 52 Week Low
- ₹17
- 52 Week High
- ₹39
- Open Price₹20
- Previous Close₹20
- Volume750
- 50 DMA₹22.44
- 100 DMA₹24.68
- 200 DMA₹31.05
Investment Returns
- Over 1 Month -5.29%
- Over 3 Month -24.14%
- Over 6 Month -22.37%
- Over 1 Year -48.87%
Smart Investing Starts Here Start SIP with Vanta Bioscience for Steady Growth!
Vanta Bioscience Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -3
- PEG Ratio
- -
- Market Cap Cr
- 14
- P/B Ratio
- 0.7
- Average True Range
- 1.08
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.7
- RSI
- 42.5
- MFI
- 42.57
Vanta Bioscience Financials
Vanta Bioscience Technicals
EMA & SMA
Current Price
₹19.89
+
0.39
(2%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹21.06
- 50 Day
- ₹22.44
- 100 Day
- ₹24.68
- 200 Day
- ₹31.05
Resistance and Support
19.89
- R3 19.89
- R2 19.89
- R1 19.89
- S1 19.89
- S2 19.89
- S3 19.89
Vanta Bioscience Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-14 | Half Yearly Results | |
| 2025-08-01 | Audited Results | (Revised) |
| 2024-12-06 | Increase in Authorised Capital | Inter alia, to consider : (1) Conversion of unsecured loans from Promoters and others into equity shares and increase in the authorized capital as per requirement |
| 2024-11-14 | Half Yearly Results | |
| 2024-07-19 | Audited Results |
Vanta Bioscience F&O
About Vanta Bioscience
- NSE Symbol
- VANTABIO
- BSE Symbol
- 540729
- Managing Director
- Mr. Dopesh Raja Mulakala
- ISIN
- INE695X01011
Similar Stocks to Vanta Bioscience
Vanta Bioscience FAQs
Vanta Bioscience share price is ₹19 As on 12 February, 2026 | 04:57
The Market Cap of Vanta Bioscience is ₹14.1 Cr As on 12 February, 2026 | 04:57
The P/E ratio of Vanta Bioscience is -3 As on 12 February, 2026 | 04:57
The PB ratio of Vanta Bioscience is 0.7 As on 12 February, 2026 | 04:57
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.